Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT07234656
Eligibility Criteria:
Inclusion Criteria:
Phase 1:
* Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse
* Partner/spouse to patients who fullfil the inclusion criteria
* Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor)
* Time since surgery: 0-120 months
* Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish
* Patients/partners/spouses able to and willing to attend online project meetings or in person at Gødstrup Hospital.
Phase 2:
* Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse
* Partner/spouse to patients who fullfill the inclusion criteria
* Patients who have undergone surgery due to localized RCC (T1-T2-T3 tumor)
* Danish speaking patients and partners/spouses. Must be able to speak, write and read Danish
* Able to receive digital communication from the hospital
* Informed consent must be signed before answering Fear of Cancer Recurrence questions
Exclusion Criteria:
Both phases, both patients and partners/spouses:
* Diagnosed with cognitive impairment
* Untreated psychiatric disorders due to non-compliance
Phase 2:
• Patients and partners/spouses who were panelists in phase 1
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT07234656
Study Brief:
Protocol Section:
NCT07234656